Drug intelligence / Profile preview

Rupixiao Pian

Development stage: Unknown
Lead developer: 辽宁上药好护士药业
Administration: Oral

Overview

Rupixiao Pian is a traditional Chinese medicine used for treating breast hyperplasia. It is manufactured by 辽宁上药好护士药业（集团）有限公司 (Liaoning Shangyao Haohushi Pharmaceutical Group Co., Ltd.) and is available in tablet form, with each tablet weighing 0.67g[1].

Brand names: 好护士 (Hao Hushi)
Other names: 乳癖消片

Beyond the preview

Go deeper on Rupixiao Pian.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rupixiao Pian.

Explore the full profile